New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 1, 2014
13:48 EDTDDD, SSYSStratasys advances after analyst calls it best positioned in 3D sector
Shares of 3D printer maker Stratsys (SSYS) are higher after UBS initiated coverage of the stock with a Buy rating in a note to investors earlier today. WHAT'S NEW: 3D printing is "a disruptive innovation with a bright future," wrote UBS analyst Steven Milunovich. Stratasys is the best way to invest in this trend, partly due to its stronger execution than its peer, 3D Systems (DDD), along with the immediate potential of Stratasys' MakerBot unit, the analyst contended. Stratasys' earnings per share should rise 18% in 2014, while 3D Systems' earnings will be unchanged this year, Milunovich predicted. He set a $125 price target on Stratasys. WHAT'S NOTABLE: Milunovich initiated coverage of 3D Systems with a Neutral rating today. He thinks the company's near-term results are likely to be "bumpy" as it invests in its products and distribution this year. However, the analyst believes that 3D Systems' profits could surge in 2015. Moreover, the company's goals of increasing its revenues by 30% annually, excluding acquisitions, while raising its gross margin to 55%-60% are "aggressive but may be achievable," the analyst contended. He set a $62 price target on 3D Systems. PRICE ACTION: In early afternoon trading, Stratasys rose about 3% to trade near $109, while 3D Systems was down nearly 2%, to $58.
News For SSYS;DDD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 23, 2015
10:53 EDTDDD3D Systems moves up on renewed takeover chatter
Subscribe for More Information
November 13, 2015
09:03 EDTDDD3D Systems announces two healthcare collaborations
Subscribe for More Information
07:56 EDTSSYSStratasys' lower spending may impair competitive moat, says Stephens
Subscribe for More Information
November 10, 2015
11:08 EDTDDD, SSYS3D printer makers tumble after ExOne results miss expectations
The shares of 3D printer makers are sinking after one of the smaller companies in the space, ExOne (XONE), reported much weaker than expected results. WHAT'S NEW: ExOne reported a per share loss of 70c, versus analysts' consensus estimate of a per share loss of 11c. The company's revenue came in at $8.9M, versus the consensus outlook of $16.9M. The 3D printer maker provided fiscal 2015 revenue of $40M against the consensus outlook of $55M. ExOne's revenue from 3D printers fell to $2.4M last quarter from $4.2M during the same period a year earlier. However, its revenue from 3D printed and other products, materials and services rose to $6.5M from $5.4M. "Machine sales growth opportunities remain very positive for ExOne and we continue to be enthusiastic about our efforts to establish a dominant market position over time," said ExOne CEO S. Kent Rockwell in a statement."But our customers' delivery scheduling and the complex revenue recognition model for certain of our products and technology have proven to be highly erratic for us to timely predict on a quarter-to-quarter basis," he added. ANALYST REACTION: In a note to investors today, Oppenheimer analyst Holden Lewis said that ExOne's results showed some improvement. The company reported its lowest loss in the past 12 months, and its cash burn rate declined, while its spending eased, the analyst stated. However, the improvement wasn't sufficient, as it still reported a "huge loss" and negative cash flow, Lewis stated. Moreover, the company's machine sales, upon which its future depends, were "poor," the analyst contended. But Lewis said that ExOne's finances did not deteriorate from Q2 levels, while its costs "are under control," its financial model is "stable," and its non-machine business performed well and "hints at value." He kept a $14 price target and Outperform rating on the shares. PRICE ACTION: In morning trading, ExOne tumbled 19% to $8.44, 3D Systems (DDD) dropped 3.5% to $9.75, Stratasys (SSYS) declined 5.5% to $25.25 and Voxeljet (VJET) slid 4% to $5.85.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use